Prioritize R&D Investments with Confidence, Clarity, and Discipline
Table of Contents
Chapter 1. Framing the R&D Portfolio Prioritization Challenge
1.1 What R&D Portfolio Prioritization Is—and Is Not
1.2 The Decisions the Portfolio Process Must Enable
1.3 Common Triggers: Annual Planning, Budget Cuts, Strategy Shifts, Acquisitions, and Technical Setbacks
1.4 Defining Portfolio Boundaries, Decision Units, and Time Horizons
1.5 Diagnostic Checklist: Signs the R&D Portfolio Needs Rebalancing
Chapter 2. Building the Portfolio Fact Base
2.1 Creating a Complete Inventory of R&D Programs
2.2 Capturing Program Stage, Spend, Timing, Milestones, and Resource Requirements
2.3 Establishing a Consistent View of Technical, Commercial, Regulatory, and Execution Risk
2.4 Identifying Interdependencies, Platforms, and Shared Technology Foundations
2.5 Template: R&D Portfolio Program Fact Sheet and Portfolio Database
Chapter 3. Designing the Prioritization Framework
3.1 Translating Corporate and Business Strategy into Portfolio Criteria
3.2 Selecting Criteria for Strategic Fit, Value, Risk, Timing, and Feasibility
3.3 Designing Scoring Scales, Weights, Thresholds, and Decision Rules
3.4 Comparing Incremental Improvements, New Products, Platforms, and Longer-Horizon Bets
3.5 Checklist: Testing a Prioritization Model for Bias, Double Counting, and False Precision
Chapter 4. Assessing Individual R&D Programs
4.1 Evaluating Strategic Relevance and Portfolio Role
4.2 Assessing Technical Feasibility and Probability of Success
4.3 Evaluating Commercial Value and Economic Potential
4.4 Incorporating Regulatory, Scale-Up, Operational, and Execution Considerations
4.5 Template: Program Assessment and Investment Recommendation
Chapter 5. Comparing and Optimizing the Portfolio
5.1 Moving from Program Scores to Portfolio-Level Decisions
5.2 Mapping Value, Risk, Time Horizon, and Strategic Balance
5.3 Identifying Overinvestment, Underinvestment, Duplication, and Portfolio Gaps
5.4 Managing Dependencies Across Programs, Platforms, and Technology Roadmaps
5.5 Step-by-Step Guide: Conducting a Portfolio Prioritization Workshop
Chapter 6. Incorporating Resource and Capacity Constraints
6.1 Translating Program Plans into Talent, Capital, Lab, and Facility Requirements
6.2 Identifying Critical Resource Bottlenecks and Capacity Conflicts
6.3 Resource Loading Across Scientists, Engineers, Clinical Teams, Pilot Plants, and Other Scarce Assets
6.4 Testing Whether Priority Programs Are Actually Executable
6.5 Template: R&D Capacity and Resource Allocation Model
Chapter 7. Making Stage-Gate and Go/No-Go Decisions
7.1 Designing Effective Stage Gates and Evidence Requirements
7.2 Defining Go, Hold, Re-Scope, Partner, and Stop Criteria
7.3 Preventing Escalation of Commitment and “Zombie” Programs
7.4 Running High-Quality Stage-Gate Decision Meetings
7.5 Checklist: Documenting Decisions, Conditions, and Required Next Evidence
Chapter 8. Scenario Planning, Portfolio Rebalancing, and Governance
8.1 Building Base, Constrained, and Accelerated Funding Scenarios
8.2 Rebalancing After Budget Cuts, Acquisitions, Strategy Changes, or Technical Setbacks
8.3 Converting Portfolio Decisions into Funding, Staffing, and Program Workplans
8.4 Establishing Decision Rights, Review Forums, and the Portfolio Governance Calendar
8.5 Preparing Executive, Investment Committee, and Board Portfolio Materials
Chapter 9. Working with External Advisors and Consultants
9.1 When External Support Adds Value in R&D Portfolio Prioritization
9.2 Types of Advisors: Strategy Consultants, Technical Experts, Industry Specialists, and Former R&D Executives
9.3 Selecting the Right Advisor for Diagnostics, Decision Support, Roadmap Development, or Implementation
9.4 Structuring the Engagement, Deliverables, Governance, and Knowledge Transfer
9.5 Engaging Independent Management Consultants Through Umbrex
Appendices
A.1 Glossary of R&D Portfolio Prioritization Terms
A.2 Common Acronyms and Abbreviations
